Antıbody to Bevacızumab ELISA

Enzyme immunoassay for the quantitative and qualitative determination of free antibodies to Bevacizumab (Avastin®) in serum and plasma.

The solid phase (MTP) is coated by the drug Bevacizumab. Due to the assay design this test measures the free antibodies which are not bound to Bevacizumab. Results could be expressed in both qualitative and quantitative manner (nanogram per mililiter-ng/mL).

Reference: IG-BB104

Barcode: 8682754930141

Legal Status: CE-Mark

Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

Related Documents

Quality Control Certificates


Avastin® is a trademark of Genentech Inc./Roche.

Required Volume (µL) 50
Incubation Time (min) 135
Sample Serum/Plasma
Package Size 96 Tests
Results in Qualitative & Quantitative (ng/mL)
Shelf Life (years) 2